Universe Pharmaceuticals ...

NASDAQ: UPC · Real-Time Price · USD
3.53
-0.03 (-0.84%)
At close: Aug 15, 2025, 2:35 PM

Universe Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Mar 31, 2025 Sep 30, 2024 Mar 31, 2024 Sep 30, 2023 Mar 31, 2023 Sep 30, 2022 Mar 31, 2022 Sep 30, 2021 Mar 31, 2021
Net Income
-3.28M 4.37M -13.1M -5.45M -715.43K -8.74M 1.73M 4.17M 7.15M
Depreciation & Amortization
269.64K 236.87K 248.86K 251K 257.78K 226.39K 292.11K 203.41K 243.47K
Stock-Based Compensation
n/a n/a n/a n/a n/a n/a -6.26M -1.6M -3.87M
Other Working Capital
-4.67K -1.85M -284.15K 2.15M -536.72K -3.14M 10.48M -5.37M -2.74M
Other Non-Cash Items
n/a -10.23M 10.41M -236.38K -252K -192.46K 5.64M 1.65M 3.59M
Deferred Income Tax
n/a -58.44K 665.15K 122.72K 556.87K -597.86K -100.41K -739.56K 71.22K
Change in Working Capital
5.58M -1.4M -653.92K 1.67M 4.95M 1.4M 4.81M -6.56M -6.12M
Operating Cash Flow
2.56M -7.08M -2.43M -3.64M 4.8M -7.9M 6.12M -2.87M 1.06M
Capital Expenditures
-96.78K -295.43K -67.66K -43.52K -646 -38.07K -55.63K -13.48M -50.88K
Cash Acquisitions
n/a n/a n/a n/a n/a -15 538.00 26.62M n/a
Purchase of Investments
n/a 313.54K -313.54K n/a n/a n/a n/a -15.33M n/a
Sales Maturities Of Investments
n/a -313.54K 313.54K n/a n/a n/a n/a 1.8M n/a
Other Investing Acitivies
n/a -115.49K n/a n/a n/a -3.81M n/a -26.62M n/a
Investing Cash Flow
-132.74K -293.63K -67.66K -43.52K -646 -3.85M -55.09K -27.01M -50.88K
Debt Repayment
1.4M 8.95M n/a n/a n/a 3.34M n/a -1.57M 2.19M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a -6.07M 6.07M -3.47M 2.08M n/a -19.99K -2.79M n/a
Financial Cash Flow
16.4M 27.89M 6.07M -3.47M 2.08M 3.34M -19.99K 2.45M 24.14M
Net Cash Flow
17.78M 20.64M 3.58M -7.67M 7.24M -8.52M 6.16M -27.92M 25.14M
Free Cash Flow
2.46M -7.37M -2.5M -3.68M 4.8M -7.94M 6.06M -16.35M 1.01M